Related Experiment Video
Updated: Mar 18, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
Serologic response to VDRL in infants with congenital syphilis: ceftriaxone vs. penicillin
Ana Nery Melo Cavalcante1, Maria Alix Leite Araújo2, Beatriz Sobreira Camilo Soares3
1Universidade de Fortaleza, Fortaleza, CE, Brazil; Sociedade Brazileira de Pediatria (SBP), Fortaleza, CE, Brazil.
Insights
Ceftriaxone offers a comparable serological response to penicillin for treating congenital syphilis (CS) in infants. This finding is crucial when penicillin allergy or unavailability necessitates alternative therapies for CS.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Penicillin is the primary treatment for congenital syphilis (CS) in pregnant women and infants.
- Alternative therapies are essential due to penicillin allergies or supply shortages.
- Evaluating ceftriaxone as a penicillin alternative for CS is critical.
Purpose of the Study:
- To compare the serological response to the Venereal Disease Research Laboratory (VDRL) test in infants with CS treated with ceftriaxone versus penicillin.
- To assess the efficacy of ceftriaxone as an alternative treatment for congenital syphilis.
Main Methods:
- A cohort study analyzed data from 383 infants with CS in Fortaleza, Brazil.
- Serological response was assessed via VDRL testing, with adequate response defined as two consecutive negative tests.
- Kaplan-Meier survival analysis compared time to VDRL negativity between ceftriaxone and penicillin groups.
Main Results:
- Fifty-six infants (14.6%) met study criteria, with 19 receiving ceftriaxone and 37 receiving penicillin.
- No statistically significant difference in the time to VDRL negativity was observed between the treatment groups (p=0.73).
- The median time to VDRL negativity was 3 months for both ceftriaxone and penicillin cohorts.
Conclusions:
- Serological response to VDRL was comparable between infants treated with ceftriaxone and penicillin for congenital syphilis.
- Ceftriaxone demonstrated similar efficacy to penicillin in achieving serological cure.
- No kernicterus or CS-related complications were reported in infants treated with ceftriaxone.
Objective:
Penicillin remains the only safe and effective drug recommended for treating syphilis in pregnant women and congenital syphilis (CS). Nevertheless, alternative therapies are needed when penicillin is contraindicated, such as in allergic reactions, or unavailable due to supply limitations. This study aimed to compare the serological response to the Venereal Disease Research Laboratory (VDRL) test in infants reported with CS and treated with either ceftriaxone or penicillin.
Method:
A non-competitive cohort study was conducted in three public maternity hospitals in Fortaleza, Ceará, Northeast Brazil. Data were extracted from notification forms in the Notifiable Diseases Information System (SINAN), medical records from maternity hospitals and outpatient clinics, and electronic records from primary care units. The serological response of infants treated with ceftriaxone and penicillin was assessed. An adequate response was defined as two consecutive negative VDRL tests performed at the intervals recommended by the Brazilian Ministry of Health. Survival curves were estimated using the Kaplan-Meier method.
Results:
Among 383 infants reported with CS, 56 (14.6 %) underwent VDRL testing in accordance with Ministry of Health guidelines. Of these, 19 (33.9 %) received ceftriaxone and 37 (66.1 %) penicillin. No statistically significant difference in time to VDRL negativity was observed between the groups (log-rank p = 0.73). The median time to negativity was 3 months in both cohorts.
Conclusions:
Serological response to VDRL was comparable between infants treated with ceftriaxone and those treated with penicillin. No cases of kernicterus or other CS-related complications occurred among ceftriaxone-treated infants.
More Related Videos
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Related Concept Videos
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...